Officially ECFMG certified! 🤩 This journey has been incredibly meaningful! Looking forward to applying for #Match2024 in #internalmedicine and keep growing as a dedicated physician and passionate researcher!

So happy to have attended the Mayo Clinic Updates in Lymphoid Malignancies 2025 meeting close to home in Truckee, CA by Lake Tahoe! Amazing to see so many leaders in the field from around the world reunited at such a charming conference in the middle of the woods! @MayoClinic

Hi #MedTwitter! I’m Jose Villamarin, a postdoc research fellow at @MayoClinic and an IMG from Ecuador 🇪🇨. Thrilled to be applying for #InternalMedicine #Match2026 I work on patient-centered care, real-world outcomes, and clinical research. Outside the lab, I’m a ⚽ soccer fan

Hi #MedTwitter I’m Sebastian from Colombia 🇨🇴 Master’s student @harvardmed research fellow @BIDMC_Medicine,applying to #InternalMedicine #Match2026 AAMC ID 15576188 When not in the hospital or lab, I’m hiking or chasing sunsets 🌅 Happy to meet peers & programs along the way!

Mayo Clinic is advancing the future of healthcare through platform thinking. At the PlatforMed Conference, leaders explored how Mayo Clinic Platform is accelerating innovation, empowering clinicians, and expanding access to high-quality care worldwide. https://t.co/6mRSGVJo05

We are proud that Mayo Clinic has been recognized once again as a leader in healthcare, a reflection of the unwavering commitment of our staff and their dedication to excellence, innovation, and putting patients first. https://t.co/lKCcbijUcG

So incredibly honored to have been part of this joint #JACC session panel! 🤩 a big thank you to all the meeting organizers of the 9th Annual @HeartinDiabetes for the opportunity to talk about the #ARISEHF trial results! @drmikefarkouh @DrCaliff_FDA @ambarish4786

Grateful to have co-lead such a meaningful and special project for our lab! Forever grateful for the unwavering support @dr_aac! Congrats to @LizCifuentesMD, Tim O’Connor and all our great co-authors! @UTSWIMchief @UTSWInternalMed https://t.co/TcZekiNVJv

From learning English just 4 years ago when I moved to this country, to doing research at the best hospital in the world, then matching into my dream specialty at @unrmed and being selected as the program’s representative for a research competition- what a journey!

So proud!! @jllbmd

Finishing my 2nd nights block of internship year in the US, and reflecting on the learning curve. Wild to see how far I’ve come, but with new cases daily—even attendings still learning—it feels like the curve never ends. Maybe we’re always climbing, and that’s the beauty of it.

-Chronic Obstructive Pulmonary Disease -Heart Failure -Diabetes Mellitus -Hypertension -Pneumonia -Atrial Fibrillation/Flutter -Acute Kidney Injury and Chronic Kidney Disease -Electrolyte Imbalances -Alcohol and Drug Withdrawal/Intoxication

During my six months as an IM resident in the U.S. healthcare system, I have seen that certain conditions are absolutely critical to manage effectively. These conditions represent approximately 60-70% of my daily patient encounters in the hospital. These include:

🚨Thrilled to share our new chapter on the role of precision medicine in obesity management, now part of the SAGES Manual of Metabolic and Bariatric Surgery! Grateful for the opportunity to contribute! @dr_aac @SAGES_Updates @OMGhanemMD https://t.co/XGDISgNlpU

As an IM resident, I am delighted to contribute to this multi-center collaboration on predicting Graves' disease recurrence, which helps guide our initial therapeutic approach. A collaborative effort with dear colleagues from the KER unit at Mayo! https://t.co/RHKp2J5sUc

Our most recent abstract on CLL from #ASH2024 is out 🤩!!! Incidence and Prevalence of Chronic Lymphocytic Leukemia in the 7-County Region Around Mayo Clinic, Rochester, Minnesota https://t.co/tQVVKb4sLN 1/6801/528824/Incidence-and-Prevalence-of-Chronic-Lymphocytic

Our melanoma study on MBL patients was recently featured in ASH Clinical News. I’m thrilled to see our hard work being shared so widely to benefit at-risk patients! @MayoCancerCare @MayoClinic CLL Precursor Condition Linked with Melanoma Risk

It’s a pleasure to continue being part of such a wonderful institution! @MayoClinic @MayoCancerCare

“An estimated 5%-10% of individuals with melanoma could be associated with underlying MBL”

New advances in flow cytometry, a high-resolution technology that enables the study of cells in the blood and their varied physical characteristics, have allowed @MayoClinic researchers to pinpoint links to several health complications, including melanoma. https://t.co/1Jhbw1k8mr

Incident Melanoma Among Individuals With Low-Count MBL: Susceptibility to melanoma appears to originate from the onset of MBL rather than CLL. If validated, there are implications regarding surveillance strategies for patients with MBL. @JCO_ASCO https://t.co/ue05dZbpw9